Stocks News Review: Bitauto Hldg Ltd (ADR) (NYSE:BITA), Jazz Pharmaceuticals plc – Ordinary Shares (NASDAQ:JAZZ), Mallinckrodt PLC (NYSE:MNK)

On Thursday, Shares of Bitauto Hldg Ltd (ADR)(NYSE:BITA), subtract -1.74% and closed at $24.81 in the last trading session. The last trading range of the stock ranges between $24.42 and $25.73. Bitauto Holdings Limited (“Bitauto” or the “Company”) (BITA), a leading provider of internet content and marketing services for China’s fast-growing automotive industry, recently declared its unaudited financial results for the third quarter ended September 30, 2016[1].

Third Quarter 2016 Highlights:

Revenue in the third quarter of 2016 was RMB1.50 billion (US$224.9 million), a 33.1% increase from the corresponding period in 2015.

Gross profit in the third quarter of 2016 was RMB958.5 million (US$143.7 million), a 33.2% increase from the corresponding period in 2015.

Operating loss in the third quarter of 2016 was RMB14.0 million (US$2.1 million), contrast to an operating loss of RMB53.2 million (US$8.0 million) in the corresponding period in 2015.

Non-GAAP operating profit in the third quarter of 2016 was RMB158.8 million (US$23.8 million), a 14.1% increase from the corresponding period in 2015.

Net loss in the third quarter of 2016 was RMB48.1 million (US$7.2 million), contrast to a net loss of RMB77.7 million (US$11.7 million) in the corresponding period in 2015.

Non-GAAP net profit in the third quarter of 2016 was RMB129.3 million (US$19.4 million), a 12.5% increase from the corresponding period in 2015.

Basic and diluted net loss per ADS in the third quarter of 2016 was RMB1.48 (US$0.22) and RMB1.48 (US$0.22), respectively.

Non-GAAP basic and diluted net profit per ADS in the third quarter of 2016 was RMB1.07 (US$0.16) and RMB1.03 (US$0.15), respectively.

Jazz Pharmaceuticals plc – Ordinary Shares (NASDAQ:JAZZ), jumped 1.53% and closed at $114.31 in the last trading session. The last trading range of the stock ranges between $112.82 and $116.80. The company’s Market capitalization is $6.74 Billion with the total Outstanding Shares of 59.89 million. Jazz Pharmaceuticals plc (JAZZ) recently declared that the company will be webcasting its corporate presentations at three forthcoming shareholder conferences.

Jefferies London Healthcare Conference in London, England on Thursday, November 17 at 8:40 a.m. GMT/ 3:40 a.m. EST. Iain McGill, senior vice president, Jazz Pharmaceuticals Europe and rest of world, will provide an overview of the company and a business and financial update.

Piper Jaffray 28th Annual Healthcare Conference in New York, NY on Wednesday, November 30, 2016 at 8:00 a.m. EST / 1:00 p.m. GMT. Bruce Cozadd, chairman and chief executive officer, will provide an overview of the company and a business and financial update.

BMO Capital Markets Healthcare Conference in New York, NY on Wednesday, December 14, 2016 at 8:00 a.m. EST / 1:00 p.m. GMT. Russell Cox, executive vice president and chief operating officer, will provide an overview of the company and a business and financial update.

Mallinckrodt PLC (NYSE:MNK), jumped 2.10% and closed at $65.19 in the last trading session. The last trading range of the stock ranges between $63.98 and $66.89. During the 52-week trading session the minimum price at which share price traded, registered at $50.90 and reached to max level of $85.83. Mallinckrodt Pharmaceuticals (MNK), a leading global specialty pharmaceutical company, declared recently the U.S. Food and Drug Administration (FDA) has approved a Prior Approval Supplement for OFIRMEV® (acetaminophen) injection available in an intravenous (IV) bag presentation, which will provide health care providers an additional delivery option.

Leave a Reply

Your email address will not be published. Required fields are marked *